Link to this page
Medical Subject Headings
| Preferred Name | Gemifloxacin | |
| Synonyms |
Factive Gemifloxacin Mesylate SB-265805 LB20304 1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo- LB-20304 LB 20304 SB265805 SB 265805 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid |
|
| Definitions |
A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000077735 |
|
| altLabel |
Factive Gemifloxacin Mesylate SB-265805 LB20304 1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo- LB-20304 LB 20304 SB265805 SB 265805 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
|
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR
|
|
| cui |
C0533545 C1321744 C0754455 C1320102 C0533546
|
|
| DC |
1
|
|
| definition |
A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
|
|
| DX |
20190101
|
|
| HN |
2019 (1997)
|
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
OKR68Y0E4T X4S9F8RL01 0
|
|
| isa | ||
| LT |
TRD
|
|
| Machine permutation |
2019; GEMIFLOXACIN was indexed under NAPHTHYRIDINES and FLUOROQUINOLONES 1997-2018
|
|
| MDA |
20180709
|
|
| MMR |
20180703
|
|
| MN |
D03.633.100.810.835.322.322 D03.633.100.612.250
|
|
| notation |
D000077735
|
|
| PA |
D059005 D000900
|
|
| prefLabel |
Gemifloxacin
|
|
| RR |
X4S9F8RL01 175463-14-6 (Gemifloxacin)
|
|
| TERMUI |
T300093 T405122 T000940977 T000940975 T681331 T300090 T300092 T300094 T300091
|
|
| TH |
NLM (1997) NLM (2004) NLM (2000) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2006)
|
|
| tui |
T109 T195 T121
|
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |